The following new articles have just been published in Allergy, Asthma & Clinical Immunology

Allergy, Asthma & Clinical Immunology

The following new articles have just been published in Allergy, Asthma & Clinical Immunology CASE REPORT Health effects of diesel engine exhaust emissions exposure (DEEE) can mimic allergic asthma and rhinitis Elopy Sibanda and Nancy Makaza Allergy, Asthma & Clinical Immunology 2019, 15:31 | Published on: 29 April 2019 Full Text | PDF RESEARCH Association of molds and metrological parameters to frequency of severe asthma exacerbation Mona Al-Ahmad, Edin Jusufovic, Nermina Arifhodzic, Tito Rodriguez and Jasmina Nurkic Allergy, Asthma & Clinical Immunology 2019, 15:29 | Published on: 29 April 2019 Full Text | PDF RESEARCH Variants in the IL17 pathway genes are associated with atopic asthma and atopy makers in a South American population Milca de J. Silva, Maria B. R. de Santana, Bruna R. Tosta, Roberta P. Espinheira, Neuza Maria Alcantara-Neves, Maurício L. Barreto, Camila Alexandrina Figueiredo and Ryan dos S. Costa Allergy, Asthma & Clinical Immunology 2019, 15:28 | Published on: 29 April 2019 Full Text | PDF RESEARCH Stability of peripheral blood immune markers in patients with asthma Nami Shrestha Palikhe, Ana-Maria Bosonea, Cheryl Laratta, Vivek Dipak Gandhi, Drew Nahirney, Angela Hillaby, Miranda Bowen, Mohit Bhutani, Irvin Mayers, Lisa Cameron and Harissios Vliagoftis Allergy, Asthma & Clinical Immunology 2019, 15:30 | Published on: 29 April 2019 Full Text | PDF

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?

Allergy, Asthma & Clinical Immunology
• Research
• Open Access

• Anne K. Ellis,
• Rémi Gagnon,
• Eva HammerbyEmail authorView ORCID ID profile and
• Andrea Lau

Allergy, Asthma & Clinical Immunology201915:27

https://doi.org/10.1186/s13223-019-0344-3

Abstract

Background

A cost-minimization analysis (CMA) was performed to estimate the economic impact of introducing the SQ house dust mite sublingual immunotherapy (SQ HDM SLIT)-tablet marketed as ACARIZAX™ (regulatory approval May 2017) for the treatment of HDM-induced allergic rhinitis in Canada (Ontario and Quebec), where house dust mite subcutaneous immunotherapy (HDM SCIT) is already an available treatment option.

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis

ORIGINAL RESEARCH

          

• Abstract
• Fulltext
• Metrics
• Get Permission

Authors Tang B, Wang J, Luo LL, Li QG, Huang D

Received 25 October 2018

Accepted for publication 12 February 2019

Published 1 April 2019 Volume 2019:14 Pages 757—766

DOI https://doi.org/10.2147/COPD.S192166

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Justinn Cochran

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Chunxue Bai

Bin Tang,¹ Jun Wang,¹ Lin-lin Luo,¹ Qiu-gen Li,^1,* Dan Huang<sup>2,*

1</sup>Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China; ²Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China

^*These authors contributed equally to this work
Purpose: The aim of this study was to investigate the comparative risks of budesonide/formoterol, versus placebo or monotherapies, for the treatment of patients with stable COPD.

Unmet needs in asthma

• Journal List
• Ther Clin Risk Manag
• v.15; 2019
• PMC6422410

Ther Clin Risk Manag. 2019; 15: 409–421.

Published online 2019 Mar 14. doi: 10.2147/TCRM.S160327

PMCID: PMC6422410

PMID: 30936704

Kevin Gruffydd-Jones

Abstract

Despite advances in the diagnosis and management of asthma, uncontrolled disease is still associated with a substantial mortality and morbidity burden. Patients often overestimate their level of asthma control while also reporting that asthma symptoms affect their quality of life and ability to work or study.

Allergic reactions after vaccination: translating guidelines into clinical practice

A. Radice¹radiceanna87@gmail.com, G. Carli², D. Macchia¹, A. Farsi²   

Show more: Authors information and Publication history

Doihttps://doi.org/10.23822/EurAnnACI.1764-1489.86

SummaryVaccination represents one of the most powerful medical interventions on global health.

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019

Allergology International

Available online 16 April 2019

open access

In Press, Corrected ProofWhat are Corrected Proof articles?

Invited Review Article

Author links open overlay panelTetsuoShioharaYoshikoMizukawa

https://doi.org/10.1016/j.alit.2019.03.006Get rights and content

Under a Creative Commons license

Abstract

The aim of this review was to provide an updated overview of drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).

What vaccines are safe for breastfeeding women?

The research reviewed all of the most common types of vaccines, including inactivated and live attenuated types, for the 'unsubstantiated concern' that they would cause harm to a nursing infant or interfere with the infant’s response to early childhood vaccinations. 

It confirmed that no routine vaccines are contraindicated in nursing mothers. However, it says that yellow fever vaccine should not be given to mothers who are breastfeeding an infant younger than nine months of age unless it is absolutely unavoidable. Meanwhile, smallpox vaccine should not be given to nursing mothers, while adenovirus type 4 and type 7 vaccine is also not recommended. 

In an accompanying editorial , Dr Arthur I. Eidelman, Editor-in-Chief of Breastfeeding Medicine said not only is there no harm in administering routine vaccinations to breastfeeding mothers, but there are benefits for both the mothers and infants, including the transfer of maternal antibodies to the infant and an enhanced antibody response. 

Philip O. Anderson. Maternal Vaccination and Breastfeeding

Breastfeeding Medicine.http://doi.org/10.1089/bfm.2019.0045 Open Access

• Online Ahead of Print:March 19, 2019
• PDF

The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

• 
  Email authorLeif Bjermer

Allergy, Asthma & Clinical Immunology201915:24

https://doi.org/10.1186/s13223-018-0314-1 

Leif Bjermer, Marit Westman, Mats Holmström and Magnus C. Wickman

Abstract

Allergic rhinitis (AR) poses a global health problem and can be challenging to treat. Many of the current symptomatic treatments for AR have been available for decades, yet there has been little improvement in patient quality of life or symptom burden over the years.